TFF PHARMACEUTICALS, INC. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/745a9a8c-e8c0-4be9-9dd7-9442d82827fe/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-21.2M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-027185 |
| FY 2022 | $-31.8M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-025454 |
| FY 2021 | $-31.0M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-014844 |
| FY 2020 | $-18.6M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-014575 |
| FY 2019 | $-11.9M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-007544 |
| FY 2018 | $-3.8M | 2018-01-24 – 2018-12-31 | evidence 0001213900-20-007544 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TFF PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income